High-Purity Eptifibatide API: Advanced Pharmaceutical Intermediate for Research and Development
Unlock cutting-edge cardiovascular research with our premium Eptifibatide API, ensuring superior purity and efficacy.
Get a Quote & SampleProduct Core Value
Eptifibatide API
Our Eptifibatide API is a high-quality synthetic cyclic peptide designed for advanced pharmaceutical research. It functions as a potent platelet glycoprotein IIb/IIIa receptor antagonist, crucial for inhibiting platelet aggregation. This makes it an indispensable component for studies related to cardiovascular diseases such as unstable angina and acute myocardial infarction.
- Explore the efficacy of Eptifibatide powder API purity in your research endeavors.
- Understand the mechanism of synthetic cyclic peptide research with this advanced intermediate.
- Utilize this advanced pharmaceutical intermediate development for novel drug discovery.
- Investigate unstable angina treatment peptide applications with our reliable Eptifibatide.
Advantages of Using Our Eptifibatide API
Exceptional Purity
Achieve reliable research outcomes with Eptifibatide boasting purity levels exceeding 99%, as verified by RP-HPLC and SDS-PAGE. This adherence to stringent quality standards is vital for accurate experimental results in cardiovascular research.
Advanced Research Applications
Leverage the properties of this synthetic cyclic peptide for critical studies. Its role as a platelet aggregation inhibitor is key for understanding thrombosis and developing new therapeutic strategies for cardiovascular conditions.
Reliable Sourcing
Source your pharmaceutical intermediate development needs with confidence. Our Eptifibatide CAS 188627-80-7 is readily available for scientific applications, supporting your project timelines and research goals.
Key Applications
Pharmaceutical Research
Eptifibatide is a critical tool for in-depth pharmaceutical research, particularly in exploring new treatments for thromboembolic disorders. Its precise mechanism makes it ideal for laboratory investigations.
Cardiovascular Treatment Studies
This synthetic cyclic peptide is central to studying cardiovascular treatments, focusing on the inhibition of platelet aggregation. Its application aids in the development of more effective therapies for patients with heart conditions.
Drug Development
As an advanced pharmaceutical intermediate, Eptifibatide plays a vital role in the drug development pipeline, contributing to the creation of next-generation antiplatelet agents and cardiovascular medications.
Scientific Investigations
Researchers can confidently use Eptifibatide for various scientific investigations, including its role in acute myocardial infarction and unstable angina, furthering our understanding of cardiac health.